How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Certara’s Steve Sibley, Vice President Regulatory Strategy, is quoted in this Pharma’s Almanac article about the challenges of balancing faster drug approvals with patient safety and efficacy. Read the article to get Steve’s thoughts on how eCTD submissions, automation, and structured content management can help streamline workflows, minimize redundancies, and ensure consistency across global filings.